GM law 'a blow for science'

German researchers and industry decry a new crop law as being detrimental to innovation

Written byNed Stafford
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The final passage of a highly restrictive genetically modified (GM) crops law is being hailed as a major victory by German Agriculture Minister Renate Künast, but the bioscience community and biotech sector see the new legislation as a blow to German science and industry.

Among the most controversial aspects of the new law are clauses holding planters of GM crops liable for economic damages to adjacent non-GM fields even if they followed planting instructions and other regulations. Opponents say this will create a financial risk some German universities, research organizations, and companies will not take.

Mark Stitt, managing director at the Max Planck Institute of Molecular Plant Physiology, told The Scientist: "I think the law, as it now stands, is going to have a very detrimental effect on innovation in Germany."

"Germany has potentially one of the most flourishing bioscience industries in the world," Stitt said. "But now, research will ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery